|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 38/10 | |
| A61K 31/70 | |||
| C07K 14/00 | |||
| C07K 7/08 | |||
| A61P 35/00 |
| (11) | Number of the document | 2994155 |
| (13) | Kind of document | T |
| (96) | European patent application number | 14794114.0 |
| Date of filing the European patent application | 2014-05-08 | |
| (97) | Date of publication of the European application | 2016-03-16 |
| (45) | Date of publication and mention of the grant of the patent | 2020-12-23 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2014/037377 |
| Date | 2014-05-08 |
| (87) | Number | WO 2014/182955 |
| Date | 2014-11-13 |
| (30) | Number | Date | Country code |
| 201361821028 P | 2013-05-08 | US |
| (72) |
WEIHUA, Zhang, US
|
| (73) |
The University of Houston System,
316 E. Cullen, Houston, TX 77204-2015,
US
|
| (54) | TARGETING THE EGFR-SGLT1 INTERACTION FOR CANCER THERAPY |
| TARGETING THE EGFR-SGLT1 INTERACTION FOR CANCER THERAPY |